for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Lionco Pharmaceutical Group Co Ltd

603669.SS

Latest Trade

7.12CNY

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

6.30

 - 

10.09

As of on the Shanghai Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
7.12
Open
--
Volume
--
3M AVG Volume
36.05
Today's High
--
Today's Low
--
52 Week High
10.09
52 Week Low
6.30
Shares Out (MIL)
509.60
Market Cap (MIL)
3,628.35
Forward P/E
--
Dividend (Yield %)
5.07

Latest Developments

More

Lionco Pharmaceutical Group to invest $10 mln to set up Hongkong-based wholly owned medicine unit

Lionco Pharmaceutical Signs Framework Agreement To Buy 25 Pct Stake In Medical Centre

Lionco Pharmaceutical Group says dividend payment date on May 10

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Lionco Pharmaceutical Group Co Ltd

Lionco Pharmaceutical Group Co.,Ltd. is a China-based company principally engaged in the research and development, production and sales of chemical prescription medicine. The Company's products are mainly categorized in to three areas: parenteral nutrition agents, anti-infectious agents and digestive system agents. The lead product of its parenteral nutrition agents is Glutamine for injection; its anti-infectious agents include Cefodizime sodium for injection and Cefathiamidine for injection, among others; its digestive system agents include Omeprazole Sodium for injection and others. The Company operates its business in domestic market.

Industry

Biotechnology & Drugs

Contact Info

Medicine Valley Industrial Park

No. 16 Medicine Valley Erheng Road

National Hi-tech Industrial Dvlpmnt Zne

+86.893.7830999

http://www.lingkang.com.cn/

Executive Leadership

Lingping Tao

Chairman of the Board, General Manager

Junke Zhang

Chief Financial Officer, Secretary of the Board

Shuangxi Li

Deputy General Manager

Jun Lu

Deputy General Manager

Tingfei Luo

Deputy General Manager

Key Stats

Price To Earnings (TTM)
21.69
Price To Sales (TTM)
2.14
Price To Book (MRQ)
2.87
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
41.90
LT Debt To Equity (MRQ)
13.86
Return on Investment (TTM)
11.48
Return on Equity (TTM)
8.76

Latest News

Latest News

BRIEF-Lionco Pharma's general manager resigns due to personal reasons

* Says General Manager Tao Linggang resigns due to personal reasons

BRIEF-Lionco Pharmaceutical Group to pay A shares annual div for FY 2016 on June 7

* Says it will pay cash dividend of 0.12 yuan(before tax)/share for 2016 to shareholders of record on June 6

BRIEF-Lionco Pharmaceutical Group unit receives GMP certificate

* Says its unit received goods manufacture practice (GMP) certificate from Hainan Food and Drug Administration

BRIEF-Lionco Pharmaceutical Group to pay cash div 1.2 yuan per 10 shares for FY 2016

* Says it plans to pay cash div 1.2 yuan per 10 shares for FY 2016

BRIEF-Lionco Pharmaceutical Group unit receives GMP certificate

* Says its wholly owned subsidiary Hainan Meida Pharmacy Co Ltd received goods manufacture practice (GMP) certificate from Hainan Food and Drug Administration

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up